首页> 外国专利> METHOD AND INTERMEDIATE RELATIONSHIPS USED IN THE PREPARATION OF STATINES, IN PARTICULAR ROSUVASTATIN

METHOD AND INTERMEDIATE RELATIONSHIPS USED IN THE PREPARATION OF STATINES, IN PARTICULAR ROSUVASTATIN

机译:特殊罗伐他汀制备他汀类药物的方法和中间关系

摘要

There is provided a process for the preparation of a compound of formula (7): formula (7) wherein R 1 represents an alkyl group, R 2 represents an aryl group, R 3 represents hydrogen, a protecting group or an alkyl group; and R 4 represents hydrogen, a protecting group or a SO 2 R 5 group where R 6 is an alkyl group, which comprises a) hydroxylating a compound of formula (1): formula (1) wherein Y represents a halo group, P 1 represents hydrogen or a protecting group, and W represents =O or -OP 2 , in which P 2 represents hydrogen or a protecting group, to give a compound of formula (2): formula (2) b) oxidising the compound of formula (2) to give a compound of formula (3): formula (3) c) coupling the compound of formula (3) with a compound of formula (4): formula (4) wherein R 3 represents a protecting group or an alkyl group, R 4 represents a protecting group or a SO 2 R 5 group where R 5 is an alkyl group; and R 6 represents (PR 7 R 8 )+X - or P (=O)R 7 R 8 in which X is an anion and R 7 and R 8 each independently is an alkyl, aryl, alkoxy or aryloxy group, to give a compound of formula (5): formula (5) wherein R 3 represents a protecting group or an alkyl group; and R4 represents a protecting group or a SO 2 R 5 group where R 5 is an alkyl group, d) when W represents -OP 2 , removing any P 2 protecting group and oxidising the compound of formula (5) to give a compound of formula (6): formula (6) and e) subjecting the compound of formula (5) when W represents =O, or compound of formula (6) to ring-opening, removal of any P 1 protecting groups, and optionally removing any additional protecting groups to give a compound of formula (7).
机译:提供了一种制备式(7)化合物的方法:式(7)其中R 1代表烷基,R 2代表芳基,R 3代表氢,保护基或烷基; R 4代表氢,保护基或SO 2 R 5基团,其中R 6为烷基,其包括a)羟基化式(1)的化合物:式(1),其中Y表示卤基,P 1表示氢或保护基,并且W表示= O或-OP 2,其中P 2表示氢或保护基基团,得到式(2)的化合物:式(2)b)氧化式(2)的化合物,得到式(3)的化合物:式(3)c)偶联式(3)的化合物式(4)的化合物:式(4)其中R 3代表保护基或烷基,R 4代表保护基或SO 2 R 5基,其中R 5为烷基。 R 6表示(PR 7 R 8)+ X-或P(= O)R 7 R 8,其中,X为阴离子,R 7和R 8分别独立地为烷基,芳基,烷氧基或芳氧基。式(5)的化合物:式(5)其中R 3表示保护基或烷基;和R4代表保护基或SO 2 R 5基团,其中R 5是烷基,d)当W代表-OP 2时,除去任何P 2保护基并氧化式(5)化合物得到式(5)化合物。式(6):式(6)和e)使W代表= O的式(5)化合物或式(6)化合物开环,除去任何P 1保护基,并任选除去另外的保护基团得到式(7)化合物。

著录项

  • 公开/公告号DK1958633T3

    专利类型

  • 公开/公告日2012-04-02

    原文格式PDF

  • 申请/专利权人 REDX PHARMA LIMITED;

    申请/专利号DK20080157487T

  • 发明设计人 MOODY DAVID JOHN;WIFFEN JONATHAN WILLIAM;

    申请日2005-03-23

  • 分类号A61K31/505;C07D309/10;C07D309/30;C07D405/06;

  • 国家 DK

  • 入库时间 2022-08-21 17:25:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号